EIM
FLXN

Essex Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Essex Investment Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-246,019
Closed -$2.2M – 479
2021
Q1 		$2.2M Buy
246,019
+61,156
+33% +$701K 0.27% 125
2020
Q4 		$2.13M Buy
+184,863
New +$2.15M 0.26% 123
2020
Q2 		– Sell
-20,000
Closed -$157K – 463
2020
Q1 		$157K Hold
20,000
– – 0.03% 298
2019
Q4 		$414K Buy
+20,000
New +$337K 0.05% 323

Other funds holding FLXN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return